Page 58 - AN-2-2

Advanced Neurology Seizures and CKD

Kidney J, 7: 442–449. Systematic review. Epilepsy Res, 113: 44–67.
https://doi.org/10.1093/ckj/sfu080 https://doi.org/10.1016/j.eplepsyres.2015.03.002
122. Malhotra K, Ishfaq MF, Goyal N, et al., 2019, Oral 134. Hesselink JM, Kopsky DJ, 2017, Phenytoin: 80 years young,
anticoagulation in patients with chronic kidney disease: from epilepsy to breast cancer, a remarkable molecule with
A systematic review and meta-analysis. Neurology, 92: multiple modes of action. J Neurol, 264: 1617–1621.
e2421–e2431.
https://doi.org/10.1007/s00415-017-8391-5
https://doi.org/10.1212/WNL.0000000000007534
135. Bansal AD, Hill CE, Berns JS, 2015, Use of antiepileptic
123. Vinters HV, Magaki SD, Williams CK, 2021, Neuropathologic drugs in patients with chronic kidney disease and end stage
findings in chronic kidney disease (CKD). J Stroke renal disease. Semin Dial, 28: 404–412.
Cerebrovasc Dis, 30: 105657.
https://doi.org/10.1111/sdi.12385
https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105657
136. Roberts WL, De BK, Coleman JP, et al., 1999, Falsely
124. Lionaki S, Hogan SL, Jennette CE, et al., 2009, The clinical increased immunoassay measurements of total and
course of ANCA small-vessel vasculitis on chronic dialysis. unbound phenytoin in critically ill uremic patients receiving
Kidney Int, 76: 644–651. fosphenytoin. Clin Chem, 45: 829–837.
https://doi.org/10.1038/ki.2009.218 137. Czapinski P, Blaszczyk B, Czuczwar SJ, 2005, Mechanisms of
125. Nayak-Rao S, Shenoy MP, 2017, Stroke in patients with action of antiepileptic drugs. Curr Top Med Chem, 5: 3–14.
chronic kidney disease: How do we approach and manage https://doi.org/10.2174/1568026053386962
it? Indian J Nephrol, 27: 167–171.
138. Patsalos PN, Berry DJ, Bourgeois BF, et al., 2008,
https://doi.org/10.4103/0971-4065.202405 Antiepileptic drugs--best practice guidelines for therapeutic
126. Kerr PG, Toussaint ND, 2013, KHA‐CARI guideline: drug monitoring: A position paper by the subcommission
Dialysis adequacy (haemodialysis): Dialysis membranes. on therapeutic drug monitoring, ILAE Commission on
Nephrology, 18: 485–488. Therapeutic Strategies. Epilepsia, 49: 1239–1276.
https://doi.org/10.1111/nep.12096 https://doi.org/10.1111/j.1528-1167.2008.01561.x
127. Jin DC, Yun SR, Lee SW, et al., 2018, Current characteristics 139. Israni RK, Kasbekar N, Haynes K, et al., 2006, Use of
of dialysis therapy in Korea: 2016 registry data focusing on antiepileptic drugs in patients with kidney disease. Semin
diabetic patients. Kidney Res Clin Pract, 37: 20–29. Dial, 19: 408–416.
https://doi.org/10.23876/j.krcp.2018.37.1.20 https://doi.org/10.1111/j.1525-139X.2006.00195.x
128. Peixoto AJ, 2019, Acute severe hypertension. New Engl J 140. Lee CS, Marbury TC, Perchalski RT, et al., 1982,
Med, 381: 1843–1852. Pharmacokinetics of primidone elimination by uremic
https://doi.org/10.1056/NEJMcp1901117 patients. J Clin Pharmacol, 22: 301–308.
129. Diaz A, Deliz B, Benbadis SR, 2012, The use of newer https://doi.org/10.1002/j.1552-4604.1982.tb02679.x
antiepileptic drugs in patients with renal failure. Expert Rev 141. Streete JM, Berry DJ, Jones JA, et al., 1990, Clearance of
Neurother, 12: 99–105. phenylethylmalonamide during haemodialysis of a patient
https://doi.org/10.1586/ern.11.181 with renal failure. Ther Drug Monit, 12: 281–283.
130. Ashley C, Dunleavy A. 2018. The Renal Drug Handbook: https://doi.org/10.1097/00007691-199005000-00012
The Ultimate Prescribing Guide for Renal Practitioners. 142. Dichter MA, Brodie MJ, 1996, New antiepileptic drugs. New
th
5 ed. Boca Raton, Florida, United States: CRC Press. Engl J Med, 334: 1583–1590.
p1–1108.
https://doi.org/10.1056/NEJM199606133342407
131. Asconapé JJ, 2014, Use of antiepileptic drugs in hepatic and
renal disease. Handb Clin Neurol, 119: 417–432. 143. Ambrósio AF, Soares-da-Silva P, Carvalho CM, et al., 2002,
Mechanisms of action of carbamazepine and its derivatives,
https://doi.org/10.1016/B978-0-7020-4086-3.00027-8 oxcarbazepine, BIA 2-093, and BIA 2-024. Neurochem Res,
132. Mintzer S, Skidmore CT, Abidin CJ, et al., 2009, Effects of 27: 121–130.
antiepileptic drugs on lipids, homocysteine, and C‐reactive https://doi.org/10.1023/a:1014814924965
protein. Ann Neurol, 65: 448–456.
144. Guerreiro CA, Guerreiro MM, Mintzer S, 2015,
https://doi.org/10.1002/ana.21615 Carbamazepine, oxcarbazepine, and eslicarbazepine. In:
th
133. Vyas MV, Davidson BA, Escalaya L, et al., 2015, Antiepileptic The Treatment of Epilepsy: Principles and Practice. 6 ed.
drug use for treatment of epilepsy and dyslipidemia: Philadelphia, PA: Wolters Kluwer. p615–625.

https://doi.org/10.36922/an.314
32
V 32 https://doi.org/10.36922/an.314
Volume 2 Issue 2 (2023) olume 2 Issue 2 (2023)